The study, published in the Lancet's eClinicalMedicine journal on Thursday, explored more than 100 million medical records of U.S. patients to see if Ozempic increased the risk of several neurological and psychiatric conditions in the first year of use compared with three common antidiabetic drugs.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/0PLMlOX
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment